Company intelligence / Profile preview

Tourmaline Capital Partners

Philadelphia, Pennsylvania, United Statestourmalinecp.com ↗

Ownership: Private
Development stage: Other

Overview

Tourmaline Capital Partners is a next-generation real estate investment and development firm specializing in Class-A office properties across the United States. In October 2024, it announced the launch of a dedicated life sciences real estate vertical with the hiring of industry veteran William D. Hunter as President of Tourmaline Life Sciences. The firm focuses on adaptive reuse and repositioning of complex infrastructure assets to serve tenants in the life sciences ecosystem, but it does not itself conduct drug discovery, development, or commercialization.

Industry: Investors

Partnerships

None disclosed specific to pharma/biotech partnerships; focus is on real estate clients

Beyond the preview

Go deeper on Tourmaline Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tourmaline Capital Partners.

Explore the full profile